Company Description

GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States.

It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.

The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.

GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

GlucoTrack, Inc.

Country	Israel
Founded	2001
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	6
CEO	Paul V. Goode Ph.D.

Contact Details

Address: 301 Rt 17 North, Suite 800 Rutherford, New Jersey 07070 United States
Phone	972 (8) 675-7878
Website	glucotrack.com

Stock Details

Ticker Symbol	GCTK
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001506983
CUSIP Number	45824Q507
ISIN Number	US45824Q5071
Employer ID	98-0668934
SIC Code	3841

Key Executives

Name	Position
Paul V. Goode Ph.D.	Chief Executive Officer
Mark Tapsak Ph.D.	Vice President of Technology
Drinda Benjamin	Vice President of Marketing
James P. Thrower Ph.D.	Vice President of Engineering
Avner Gal MBA, MSc.EE	Co-Founder, Chairman Emeritus, Consultant and Member of Scientific and Clinical Advisory Board
David Malka BA	Co-Founder
James S. Cardwell	Chief Financial Officer

Latest SEC Filings

Date	Type	Title
Apr 1, 2024	DEF 14A	Other definitive proxy statements
Mar 28, 2024	10-K	Annual Report
Mar 22, 2024	PRE 14A	Other preliminary proxy statements
Feb 16, 2024	8-K	Current Report
Jan 11, 2024	8-K	Current Report
Jan 3, 2024	SC 13G	Statement of acquisition of beneficial ownership by individuals
Jan 2, 2024	8-K	Current Report
Nov 30, 2023	8-K	Current Report
Nov 14, 2023	10-Q	Quarterly Report
Oct 13, 2023	8-K	Current Report

View All SEC Filings